Treatment Methods for Early and Advanced Prostate Cancer

by Kirby; Roger S.

• ISBN13: 9780415458931
• ISBN10: 0415458935
• Edition: 1st
• Format: Hardcover
• Copyright: 2008-05-01
• Publisher: CRC Press

Summary

Prostate cancer is treated in a number of different ways, depending on a host of different factors, ranging from the severity of the cancer, the health of the patient, their age, and their own personal choice of treatment. Whether the choice is open or laparoscopic surgery, laser treatment or cryoablation, ultimately, the options open to the urologic surgeon today are modeled and defined specific to the patient's individual needs.Treatment Methods for Early and Advanced Prostate Cancer will focus on the "how to treat" scenario faced by urologic surgeons treating all stages of prostate cancer by examining all the methods used to treat the condition, both its early and advanced stage.Specifically targeting the fully qualified urologic surgeon, but also highly useful for residents and trainee surgeons wishing to learn and improve their treatment techniques, Treatment Methods for Early and Advanced Prostate Cancer will undoubtedly prove an extremely popular tool indeed.

Table of Contents

General considerations affecting treatment options for patients with prostate cancer	p. 1
Mortality trends in prostate cancer	p. 3
Decision-making for men with prostate cancer	p. 9
Practical and realistic lifestyle changes and supplements for the man concerned about prostate cancer: What do I tell my patients?	p. 15
Preservation of sexual function after treatment for prostate cancer	p. 33
Quality-of-life instruments for prostate cancer	p. 41
Treatment options for localized prostate cancer	p. 45
Comparison of treatment modalities for localized prostate cancer using quality-of-life measures	p. 47
Natural history and expectant management of prostate cancer	p. 59
Clinical trials comparing expectant management to definitive treatment of prostate cancer	p. 63
Anatomic considerations in radical prostatectomy	p. 69
Anatomic radical retropubic prostatectomy	p. 81
Radical retropubic prostatectomy: contemporary modifications	p. 95
Role of lymphadenectomy in prostate cancer	p. 101
Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy	p. 107
Radical perineal prostatectomy	p. 115
Laparoscopic and robotic radical prostatectomy	p. 123
Vattikuti Institute prostatectomy: a robotic technique for the management of localized prostate cancer	p. 129
Radical prostatectomy: making the transition from open to robotic surgery	p. 137
Role of surgery in the management of high-risk localized prostate cancer	p. 143
Prevention and management of complications associated with open radical retropubic prostatectomy	p. 151
External beam radiotherapy for the treatment of prostate cancer	p. 159
Brachytherapy for the treatment of prostate cancer	p. 175
High dose rate [superscript 192]Ir as monotherapy or as a boost: the new prostate brachytherapy	p. 187
MRl-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate	p. 195
Hyperthermia for treatment of localized prostate cancer	p. 201
Initial management of high risk early stage prostate cancer: radiation	p. 205
Management of biochemical recurrence following radiation therapy	p. 213
Cryotherapy as primary therapy for prostate cancer	p. 221
Cryotherapy as salvage therapy for prostate cancer	p. 227
Neoadjuvant and adjuvant hormonal therapies for prostate cancer: data review and patient perspectives	p. 233
The assessment and management of urinary incontinence in patients with prostate cancer	p. 247
Rehabilitation of sexual function following definitive treatment of local prostate cancer	p. 257
The limitations of evidence-based comparisons of treatment for localized prostate cancer	p. 265
Reflections on prostate cancer: personal experiences of two urologic oncologists	p. 269
Coping with a diagnosis of prostate cancer: the patient and family perspective	p. 275
Treatment of locally advanced and metastatic prostate cancer	p. 277
Androgen deprivation for the treatment of prostate cancer: general principles	p. 279
Hormonal therapy for prostate cancer: optimization and timing	p. 285
Controversies in hormone treatment for prostate cancer	p. 291
Androgen deprivation therapy: the future	p. 295
Intermittent androgen suppression for prostate cancer: rationale and clinical experience	p. 307
Antiandrogen withdrawal syndromes: pathophysiology and clinical implications	p. 317
Chemotherapy for advanced prostate cancer	p. 327
Radiotherapy for the treatment of locally advanced and metastatic prostate cancer	p. 341
Use of bisphosphonates in the management of osseous metastases	p. 359
Managing the complications of advanced prostate cancer	p. 365
Principles of palliative care and psychosocial support of the metastatic prostate cancer patient	p. 375
The promise of immunotherapy in prostate cancer: from concept to reality	p. 379
Role of the primary care professional in the care of the patient with prostate cancer: a UK perspective	p. 389
Index	p. 395
Table of Contents provided by Blackwell. All Rights Reserved.